MLCAC.PA falls 9.62% to €14.10 on EURONEXT 20 Feb 2026: outlook and targets

MLCAC.PA stock dropped 9.62% to €14.10 at market close on EURONEXT on 20 Feb 2026, making it one of the session’s top losers. The decline followed an intraday gap from an open at €16.40 to a low of €14.10, on volume 6 shares versus an average volume of 5. Investors will watch valuation and liquidity metrics after the move, given a trailing EPS of €0.14 and a reported PE of 100.71.

MLCAC.PA stock: price action and session summary

The main fact is the intraday sell-off: Lombard & Medot SA (MLCAC.PA) closed at €14.10, down €1.50 or 9.62% from the previous close of €15.60, with a day high of €16.40 and day low of €14.10. Trading volume was 6 shares versus an average of 5, indicating thin liquidity and amplified moves on small flows.

Fundamentals and valuation for MLCAC.PA stock

Lombard & Medot SA trades on EURONEXT in the Consumer Defensive sector and shows a mixed fundamentals picture with book value per share €28.23, cash per share €0.24, and an EPS of €0.14. Market capitalisation is roughly €6,895,436.00, price-to-book sits at 0.50, and price-to-sales is 0.61, highlighting a low revenue multiple but stretched earnings valuation given the reported PE of 100.71.

Technicals and short-term trend for MLCAC.PA stock

Technicals point to neutral momentum after the drop: the RSI is 46.59, MACD histogram 0.03, and the 50-day average is €14.55 versus a 200-day average of €14.89, suggesting price near medium-term averages. Bollinger Bands run from €12.79 to €16.33, so the close at €14.10 sits close to the middle band and does not yet confirm a sustained downtrend.

Meyka AI rates MLCAC.PA with a score out of 100 and technical grade

Meyka AI rates MLCAC.PA with a score out of 100: 63.31 / 100 (Grade B — Suggestion: HOLD). This grade factors S&P 500 and sector comparisons, industry peers, financial growth, key metrics, forecasts and analyst signals. The grade reflects solid tangible book value €26.21 per share but weak cash flow conversion and elevated net debt to EBITDA ratios.

Forecasts and price targets for MLCAC.PA stock

Meyka AI’s forecast model projects a yearly price target of €15.17, implying an upside of about 7.59% from the current €14.10 close; the model also lists a monthly projection at €21.08. Realistic near-term targets for investors are a conservative €13.00, a base case €15.50, and a bullish €21.08, all model-based figures and not guarantees.

Catalysts, risks and sector context for MLCAC.PA stock

Key catalysts include stronger export volumes, inventory reduction and margin improvements in the Beverages – Wineries & Distilleries industry, while risks include thin liquidity, long inventory days (about 1,136.83 days) and leverage with a debt-to-equity of 1.13. The broader Consumer Defensive sector has YTD performance near 7.50%, which may cushion downside if company fundamentals improve.

Final Thoughts

MLCAC.PA stock closed the session on 20 Feb 2026 as a top loser, finishing at €14.10, down 9.62% on low volume. Fundamentals show strong book value €28.23 per share but limited earnings power with EPS €0.14 and a stretched trailing PE 100.71. Meyka AI projects a yearly target of €15.17, implying a 7.59% upside from today’s price, while a monthly scenario at €21.08 would represent higher upside but carries more model risk. Given thin trading (volume 6), elevated inventory days and modest interest coverage 1.08, we classify the move as liquidity-driven rather than a clear structural deterioration. For traders, watch a close below €14.10 for follow-through and a return above €14.55 (50-day average) for stabilization. These forecasts are model-based and not guarantees; consider position size limits and the company’s Consumer Defensive context on EURONEXT when assessing risk.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.